Diligence memo · auto-generated · as of July 2, 2026
ValenzaBio, Inc.
ValenzaBio, Inc. looks fair against its niche peers and is dormant on financing cadence.
Businessfiled
ValenzaBio, Inc. operates in Other, based in BETHESDA.
Sector still resolves to a broad 'Other' bucket, so operating comparables below are weaker than for a tightly-classified peer.
No verified homepage on file yet — operating evidence is limited to the public record.
Capital & rounds (filed)filed
ValenzaBio, Inc. has raised $94M in disclosed capital across 2 recorded rounds, aggregated from public filings. Its latest round is modeled as Series C (a $40M–$100M round).
Largest single filing: $79M on 2021-03-25.
Most recent recorded round closed around 2021-03-25.
Valuation (modeled)modeled
Provath models ValenzaBio, Inc. at approximately $1.2B (range $307M–$2.8B). This is an algorithmic estimate from round sizes and same-niche peers — not a quoted or reported figure.
Read: Fair. Modeled value is 1.44× the median modeled value of Series C Other companies in 2019–2021 (190 peers) — value vs value, same stage and era. Within the normal band (144% of peer median) for its niche.
Financing rhythm & timingmixed
Historic cadence: a new round about every 13 months.
Last raise 5.3 yr ago; this sector typically re-raises about every 11 months.
Silent for over 3× the sector's normal cadence.
The last round stepped up 5.5× from the prior — scaling.
Comparablesmixed
Capital scale ranks ahead of 96% of Other peers (25015 compared).
Modeled value ranks above 97% of those peers.
Closest niche peers: Lonnie Ray Williams Jr Trust, Ault Life Sciences, Inc., Watchtower Topco, LLC, Watchtower Management Holdco, LLC, Alphaeon 1 LLC.
Peoplefiled
4 named people on file across officers, directors and signatories.
Risks & flagsmixed
Financing has been silent well beyond sector cadence — possibly defunct, acquired, or paused.
Broad sector classification weakens peer comparison.
No clearly named CEO/founder/principal in the surfaced records — key-person evidence is thin.